In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was better than a medication called metformin at… read more.
Roche announced that the FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic retinopathy (DR), a potentially blinding condition that affects almost 10 million… read more.
A simple ultrasound of a patient’s thigh or shoulder muscle may detect insulin resistance before it progresses to type 2 diabetes or even prediabetes. In a study, Michigan… read more.
A landmark narrative review published by the Bone and Diabetes Working Group of the International Osteoporosis Foundation (IOF) Committee of Scientific Advisors reveals critical insights into how diabetes… read more.
Biomea Fusion, a clinical-stage diabetes and obesity medicines company, announced the presentation of new preclinical and clinical data for icovamenib, the company’s investigational oral menin inhibitor, at the… read more.
Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat diabetes, appears to reduce monthly migraine days by more than half, researchers reported on June 20, 2025 at… read more.
Canada can learn from England’s successful diabetes prevention program to build its own programs to tackle diabetes prevention across the country, argue authors in an analysis in CMAJ (Canadian Medical Association… read more.
Amgen announced full results from Part 1 of the Phase II study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type… read more.
A new study from the University of Colorado Anschutz Medical Campus shows that primary care clinics can successfully help patients start using continuous glucose monitors (CGMs), which track blood sugar… read more.
An intensive low-energy diet programme, similar to the NHS Type 2 Diabetes Path to Remission, significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight who… read more.
Abbott, a global leader in continuous glucose monitoring (CGM) biowearable technology announced that it has entered a first-of-its-kind agreement to integrate data from its leadiing Libre CGM systems… read more.
BioMarin Pharmaceutical Inc. announced new data from studies of Voxzogo (vosoritide), demonstrating meaningful impact on tibial bowing in children with achondroplasia and investigational early efficacy results in other skeletal… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
